Overview
- Legal name
- QUVA PHARMA, INC.
- Registered location
- SUGAR LAND, TX, USA
- Website
- Company website ↗
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Latest award activity
- May 29, 2026
Read company summary
QUVA PHARMA, INC. is associated with UEI MUABDCZXMLG4 and CAGE 7VLA4 in public federal records. AcornBids currently links 7 prime awards totaling $727.8K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Pharmaceutical Preparation Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists SUGAR LAND, TX, USA.
At a glance
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- QUVA PHARMA, INC.
- UEI
- MUABDCZXMLG4
- CAGE
- 7VLA4
- Registered address
- 3 SUGAR CREEK CENTER BLVD STE 250, SUGAR LAND, TX, 77478, USA
- Registration status
- Active
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- SAM activation
- Nov 4, 2025
- Initial registration
- May 25, 2017
- Entity start
- Aug 7, 2015
- SAM updated
- Nov 4, 2025
- Registration expires
- Nov 4, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N98026P00592OUTSOURCING PCAS AND EPIDURALS FOR PATIENTS CARE FROM QUVA PHARMA, INC. | Department of Health and Human Services | $110.0K | May 26, 2026 | May 25, 2027 |
| 75N90020F00001QUVA PHARMA, INC.:1327585 [POTS: 20-001401] | Department of Health and Human Services | $45.7K | Mar 6, 2020 | Oct 31, 2020 |
| 75N90025P00053IV MEDICATIONS QUVA PHARMA, INC.:1327585 [25-000665] | Department of Health and Human Services | $25.0K | Oct 29, 2024 | Sep 30, 2025 |
| 75N90025P00194PHARMACEUTICALS QUVA PHARMA, INC.:1327585 [25-000116] | Department of Health and Human Services | $100.0K | Feb 19, 2025 | Feb 18, 2026 |
| W81K0019P0334ROPIVACAINE 0.2% IN SODIUM CHLORIDE PF | Department of Defense | $442.6K | Oct 1, 2019 | Sep 30, 2024 |
| 75N90025D00001NON PATIENT-SPECIFIC STERILE COMPOUNDED PHARMACEUTICAL PRODUCTS FOR PATIENTS IN THE NIH CC ON AN AS CALLED IN BASIS. | Department of Health and Human Services | $250.0K | Dec 4, 2024 | Not available |
| 75N90019F00043QUVA PHARMA, INC.:1327585 [19-017387] | Department of Health and Human Services | $4.5K | Sep 30, 2019 | Sep 26, 2020 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Nov 4, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | May 25, 2017 |
| Entity start | Aug 7, 2015 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| LILLIAN LEE-WARNER | Government business | Contact method not published | SAM registration | Not available |
| LILLIAN LEE-WARNER | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
About QUVA PHARMA, INC.
What products and services appear in its federal awards?
Recorded award industries: 325412 — Pharmaceutical Preparation Manufacturing.
Recorded products and services: 6505 — Drugs and Biologicals; 6515 — Medical and Surgical Instruments, Equipment, and Supplies.
Examples from recent award records:
- OUTSOURCING PCAS AND EPIDURALS FOR PATIENTS CARE FROM QUVA PHARMA, INC.
- QUVA PHARMA, INC.:1327585 [POTS: 20-001401]
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
3 SUGAR CREEK CENTER BLVD STE 250, SUGAR LAND, Texas 77478, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
325412 — Pharmaceutical Preparation Manufacturing.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Defense; Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit